Ironwood Pharmaceuticals Inc. (IRWD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Ironwood Pharmaceuticals ...

    NASDAQ: IRWD · Real-Time Price · USD
    1.55
    -0.06 (-3.73%)
    At close: Oct 03, 2025, 3:59 PM
    1.50
    -3.23%
    After-hours: Oct 03, 2025, 07:53 PM EDT

    Ironwood Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 351.41M 442.74M 410.6M 413.75M
    Cost of Revenue
    		 2.01M 1.57M 1.42M 1.52M
    Gross Profit
    		 343.86M 442.74M 409.18M 412.23M
    Operating Income
    		 93.12M -945.43M 250.34M 232.26M
    Interest Income
    		 4.47M 18.97M 9.5M 726K
    Pretax Income
    		 65.2M -948.07M 252.42M 200.66M
    Net Income
    		 880K -1B 175.06M 528.45M
    Selling & General & Admin
    		 144.27M 158.31M 115.99M 111.13M
    Research & Development
    		 111.42M 116.08M 44.27M 70.41M
    Other Expenses
    		 -4.96M 1.11B -1.42M -70.45M
    Operating Expenses
    		 250.73M 1.39B 158.84M 111.09M
    Interest Expense
    		 33.03M 21.63M 7.6M 31.15M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 258.29M 1.39B 160.26M 181.49M
    Income Tax Expense
    		 64.32M 83.49M 77.36M -327.79M
    Shares Outstanding (Basic)
    		 159.08M 155.44M 154.37M 162.25M
    Shares Outstanding (Diluted)
    		 160.08M 155.44M 186.31M 164.42M
    EPS (Basic)
    		 0.01 -6.45 1.13 3.26
    EPS (Diluted)
    		 0.01 -6.45 0.96 3.21
    EBITDA
    		 100.24M -924.87M 261.44M 233.33M
    EBIT
    		 98.23M -926.44M 260.02M 231.81M
    Depreciation & Amortization
    		 2.01M 1.57M 1.42M 1.52M

    Add to Watchlist